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performed tn 42 pts in 3 groups; VM undergoing revascularizatJen (R~ 
pts with Ischemic ca.'diomyopathy on increasing medical therapy t~'-~. • 
and dilated eardiomyopathy (DCM). Peak rata.pressure product (RPr: :~ ~s 
derived from hemodynamlca recorded duflng axerclsa and METS were ,, ,aa- 
sured from expired gas analysis. VM was defined by mismatch at pesdren 
emlasion tomagmphy or low-dose a ~ n  at dobutsmlne echo. 
Rasutts, Groups were Comparabio with respect o age and functional status 
before intervention. Change (ch) in RPP and METS at fo,ow-up ~n RVS group 
exceeded that in lhe remainder;, 
. _ Age Pre RPP Ch RPP Pm METS Ch METS 
RVS (n,= 14) 65+9 '19.1.4.1 S.5 ± S.3 4.5-~ 1.0 ' '1"12:1:1.0 
MED (n - t4) 53 ± 6 22.0 =1:6.8 0.2 :E 6.9 4.8 ± 1.2 0.5 • 1.3 
DCM (n = 14) 54±7 2~3 ± 9.~. 0.9±4.8 5.2 :t: 1.9 0.44 * 0.8 
p (RV.S v~)  ...... <o,~! .... o.18 <0.005 0.32 0.0~ 
Extent of VM in the RVS gro~, was 38 ~: 18% of the left ventricle by 
positron emission tomngrsphy and 43 ± 18% by dobutamlno echo. Functional 
improvement in the RVS group nerresponded to an Improvement of ejection 
fracti0n from 26 + 6 to 30 -~ 8%, p < 0.01. 
Conclusions. RVS ~I VM offem a unique opportunity to improve functional 
capacity in pts with left ventdcolar dysfunction. 
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~ Cardiac 31P-MR Spe~roscopy  Dur l rg  Dobutamine 
Stress In Older Elite Cycl ists With Left Vsntr icular 
Hypertrophy 
Hildo J. Lamb, Babette M, RuIm, Hugo P. Beyerbacht, Hubert W. Vltegsn, 
Albert de Roos, Ernst E. van der Well. Univers#y Hnsp~taiLe~den, and the 
Interuniverstty Cardiology I~e ,  The Netherlands 
The phasphocreatina (PCr) to adenosinatdphosphate (ATP) ratio (PCr/ATP) 
obtained at rest and dudng dobutamine stress in 12 older elite cyclists with 
left ventdcular hypertrophy (LVH) (mean age 37 years) was Compared to the 
PCr/ATP rath~ acquired in 11 healthy conlrol subjects (mean age 40 years), 
31P-MR spectroscopy was performed at 1.5-T (Gymscan $15) using a 10 
cm diameter surface coil and a 10 minute 3D-ISIS protocol with a dobutamine 
dose of 40/xg/kg/min. Average PCr/ATP values were similar in athletes and 
controls: 1.42 ± 0.16 and 1.34 :t: 0.18 respectively at rest (p ~ 0.27), and 1.22 
:t: 0.15 and 1.16:1:0.17 respectively during stress (p = 0.37) (see figure). 
H~:  C-~C ~ATP ratios at ~ and dtudn8 do1~tamin¢ 
• ~ . . . . . . . . . . . . . . . . .  ~ /~ 
rest stress r~Z 
The observed decrease in PCr/ATP due to dobutamine stress was similar 
in athletes and controls, 0.20 4- 0.20 and 0.18 :E 0.16 respectively (p = 0.80). 
We conclude that the PCrlATP ratio decreases to the same extent in older 
cyclists with LVH and healthy controls due to dobutamlne stress. Accordingly, 
long term athletic training, resulting in LVH, is not associated with changes 
in the cardiac high energy phosphate metabolism. 
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Ftbflnolytic Activity After Maximal Exercise in Men 
Wlth and Wlthout a History of  Myocardial Infarction 
Be FemhalI, James Mil~nl, Patrick A. Gorn~n, Donald C. Paup. George 
Washington University, Washington, DC 
Exercise ircreasea overall fibrinolytic activity, but its effect in patients with 
a history of myocardial infarction (MI) is not clear. We compared the effect 
of maximal exemise on tissue plasroinngan activator (t-A) and plasminogan 
activator inhibitor-1 (PAl-1) in 13 men with a history of MI and 11 men with no 
history of ML The groups were matched on age (58.2 ~: 7.8 vs 57.6 :E 6.3 yrs) 
and physical activity. All subjects underwent maximal treadmill exercise with 
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, metabolic measurements. MI patients were net asked to discontinue their 
medinations prior to testing~ Blood was co,acted before and immed/ately 
after exercise, t-PA and PAl-1 activity were analyzed using chmmogenic 
substrates with commercially available kits, and were corrected for changes 
in plasma volume. The MI group had signircantly (p < 0.05) lower maximal 
oxygen uptake (27.8 vs 35.9 ml.kg -1.min -t)  And maximal heart rate (140 vs 
157 bpm) compared to ~osa without MI. 
As shown in the tlgure, beth groups significantly Increased t-PA activity (p < 
0.05) and decreased PAl-1 aclivity (p < 0,05) following maxirr~ exercise, but 
there were no differences between groups. Thus, the fibdnolytic responses 
of physically active men with ~ history of MI did not differ from those without 
a history of ML 
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Evidence for  Attenuated Heart Rate Control  W'dh 
Beta Blockade in Women With Heart Disease Oudng 
Pregnancy: A Pharmacokinetic and 
Pharmacodynami¢ Study 
Ud E l~am, Agneta Hurst, Awabam Shoton, Kdstina Hoffman-Willey, 
Janet Johnson, Robert Kod~ USC School of MecE, cine, Los Angeles, C. ~. 
Clinical observation suggesting an attenuated response to BB during preg- 
nancy has not ~ valide.ted. We, therefore, compare¢l heart rate {HR) 
~sponse to arenOlOl at rest ane exercise ~ the pP.armacokinetics ~ the 
orug in the 3rd gestational trimester (TT) and 6 wks post partum (PP). 50 mg 
of atenctol q 12 hrs was used in 10 lOtS requiting BB therapy dudng preg- 
nancy. Data cofle¢led included: HR Copra) at rest, H.~ at 6 mtn of treadmill 
exercise (modified Naughfon protcool) just before (t == 0) and 3 hrs after drug 
aomlnistration, ateneiol plasma (APC) and udne concentrations. 
o ~o~ ~ ho=,s 
.............. ~ ~ , ~ - - - - ~ - - - ~  
~e~n~H~ ~e,s 6o~:7 <01os ~*"8 .......... ~e  ~o.os 
Exercise HR 108:E 15 91~11 <0.05 100,6 87~7 <0.05 
~ (ng/n~) 109,47 116:t:79 NS 286:t:105 304±142 NS 
p < o.os,~'n" . . . . . . . . . . . . . . . . . . . . . . . .  
In addition, no difference was found in atenetol clearance (0.10.4- 0.03 vs 
0.12 ± 0.04 1/P.g/hr) And volume of distdbulion (0~75 :f: 0.24 vs 0.71 :I: 0.22 
1/kg) at TT and PP. 
Conclusion: 1) Rasing and exercise HR on atenelof therapy are higher in 
TT than in PP; 2) Augmented HR dudng TT is net related to lower ateneto! 
plasma concentraBons or change in volume of disth1~ition; 3) These findings 
indicate the need for increased doses of BB for heart rate control dudng 
gestation in pts with cardiac disease. 
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prol=fe.one as Ac, m Oral Lo~ing Therapy in the 
- uonvemon of Recent Onset Altial Fibrillation Is 
Safe and Effective 
A. Capucoi, FACC FESC on behalf of the SATE Group Irwestigators. 
Cardio/o~ Oept,, P/asenz~ 
Aim of this muiticenter andomized study was to evaluate the safety of 
Pmpafenene (PRF, 600 mg acute oral loading dose) in pts with recent onset 
(_ 46 h) Atrial Fibdllatlon (AF) and to observe the effect on the ventdcular 
rate dudng AF of PRFgiven as single drug or associated with digitalis (D). 
246 pts ware enrolled divided into 4 randomized groups: PRF(600 mg); PRF 
p~s D (1 n~2 h); q~ni~ne (Q) (1375 m~12 h) + D; placebo (t~). The 246 
pts (127 males and 119 females; mean age 58.7 :b 10) were comparable 
as clinical findings. 76% of the patients had net any organic heart disease. 
Resu/ts (*p < 0.05): 
Treatment Efficacy % .................... Conversion time (hr) 
3 hours 6 hours 12 hours 24 hours 
PRF 42" 56 66 7'2 4.0~ 4.t* 
PRF + D 5Q* 74* 82" 88' 5.0 -~ 8.6 
Q+D 3Q 64 77 84 5.44-4.5 
PI 27 47 57 77 7.8±7.2 
Atrial flutter > 2:1 was observed in 46 pts: PRF = 12; PRF+ O = 12; Q 
+ D == 9; PI = 13. No one episode of 1:1 col¢luction was recorded by Holier 
